Concomitant etoposide and cisplatin provided improved survival compared with docetaxel and cisplatin in patients with locally advanced non-small cell lung cancer treated with chemoradiotherapy


Sen F., Tambas M. , Ozkaya K. , Guveli M. E. , Ciftci R. , Ozkan B. , ...Daha Fazla

MEDICINE, cilt.95, sa.30, 2016 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 95 Konu: 30
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1097/md.0000000000004280
  • Dergi Adı: MEDICINE

Özet

Presently, there is no consensus regarding which chemotherapy regimen is best to administer with radiotherapy in patients with locally advanced non-small-cell lung cancer (LA-NSCLC). Herein, our aim was to compare the outcome of patients treated with either etoposide-cisplatin (EP) or docetaxel-cisplatin (DP) in this curative setting.